No description
-
2019 (v1)PublicationUploaded on: April 14, 2023
-
2021 (v1)Publication
No description
Uploaded on: February 4, 2024 -
2019 (v1)Publication
No description
Uploaded on: March 27, 2023 -
2010 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2007 (v1)Publication
No description
Uploaded on: March 31, 2023 -
2010 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2019 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2020 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2007 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2006 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2006 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2013 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2019 (v1)Publication
Objectives: The aim of this six-month open feasibility study was to evaluate skin blood perfusion and clinical symptom changes during aminaphtone treatment in patients with either primary or secondary Raynaud's phenomenon to systemic sclerosis. Methods: Ninety-two patients referring for Raynaud's phenomenon have been enrolled in November during...
Uploaded on: April 14, 2023 -
2012 (v1)Publication
No description
Uploaded on: April 14, 2023